Xiaoping Chen
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 25
- Drug Transport and Resistance Mechanisms 9
- Cancer-related Molecular Pathways 3
- Metal complexes synthesis and properties 3
- Inflammatory Biomarkers in Disease Prognosis 2
- Colorectal Cancer Surgical Treatments 1
- Co-authors
- Tingting Hong (3 shared papers)Xiaohong Wu (2 shared papers)Shuhong Liu (1 shared paper)Jian Yang (1 shared paper)Yuanqing Gu (1 shared paper)Xiaomin Wang (1 shared paper)Xuan Wang (1 shared paper)Elisa de Stanchina (3 shared papers)
- Journals
- Cancer Biomarkers (2 papers)Frontiers in Pharmacology (1 paper)Regulatory Toxicology and Pharmacology (1 paper)Molecular Biology Reports (1 paper)Annals of Human Genetics (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoping Chen
31 papers receiving 491 citations
Peers
Comparison fields: 5 of 88
- Oncology 221
- Pharmaceutical Science 18
- Molecular Biology 168
- Immunology 48
- Internal Medicine 7
Countries citing papers authored by Xiaoping Chen
This map shows the geographic impact of Xiaoping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Chen more than expected).
Fields of papers citing papers by Xiaoping Chen
This network shows the impact of papers produced by Xiaoping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Chen. The network helps show where Xiaoping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 87 | |
| 2 | 2024 | 59 | |
| 3 | 2008 | 46 | |
| 4 | 2012 | 33 | |
| 5 | Clinical relationship between MDR1 gene and gallbladder cancer. | 2004 | 26 |
| 6 | 2004 | 25 | |
| 7 | 2009 | 24 | |
| 8 | 2017 | 23 | |
| 9 | 2021 | 21 | |
| 10 | 2021 | 17 | |
| 11 | 2002 | 16 | |
| 12 | 2019 | 15 | |
| 13 | 2017 | 14 | |
| 14 | 2004 | 12 | |
| 15 | 2016 | 11 | |
| 16 | 2014 | 11 | |
| 17 | 2018 | 9 | |
| 18 | 2022 | 6 | |
| 19 | Effect of pitavastatin in different SLCO1B1 backgrounds on repaglinide pharmacokinetics and pharmacodynamics in healthy Chinese males. | 2013 | 6 |
| 20 | 2010 | 5 |
About Xiaoping Chen
Xiaoping Chen is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Pathology and Forensic Medicine and Pharmacology, having authored 31 papers that have together received 500 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Cancer-related Molecular Pathways (3 papers), Metal complexes synthesis and properties (3 papers), Ferrocene Chemistry and Applications (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Cancer Mechanisms and Therapy (2 papers) and Colorectal Cancer Surgical Treatments (1 paper). The work is most often cited by research in Oncology (221 citations), Pharmaceutical Science (18 citations), Molecular Biology (168 citations), Immunology (48 citations) and Internal Medicine (7 citations). Xiaoping Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Tingting Hong, Xiaohong Wu, Shuhong Liu, Jian Yang, Yuanqing Gu, Xiaomin Wang, Xuan Wang, Elisa de Stanchina, Jianying Liang and Haitao Wu. Their work appears in journals such as Cancer Biomarkers, Frontiers in Pharmacology, Regulatory Toxicology and Pharmacology, Molecular Biology Reports and Annals of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.